Edgestream Partners L.P. Decreases Stake in Integer Holdings Co. (NYSE:ITGR)

Edgestream Partners L.P. trimmed its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 46.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,910 shares of the medical equipment provider's stock after selling 10,354 shares during the period. Edgestream Partners L.P.'s holdings in Integer were worth $1,578,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of ITGR. Mather Group LLC. raised its holdings in Integer by 304.3% during the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Huntington National Bank increased its position in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 268 shares in the last quarter. R Squared Ltd acquired a new position in shares of Integer during the 4th quarter worth $44,000. Versant Capital Management Inc boosted its position in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after buying an additional 183 shares in the last quarter. Finally, Principal Securities Inc. grew its stake in Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after acquiring an additional 152 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Remove Ads

Integer Trading Down 0.5 %

Shares of ITGR stock traded down $0.64 on Friday, reaching $117.76. 2,991,416 shares of the stock were exchanged, compared to its average volume of 369,482. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock has a market cap of $3.96 billion, a P/E ratio of 35.05, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The firm has a 50 day moving average of $134.43 and a two-hundred day moving average of $132.75. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analysts' expectations of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. On average, research analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on ITGR. KeyCorp increased their price target on shares of Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Wells Fargo & Company reissued an "overweight" rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Citigroup raised their price target on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. Finally, Benchmark boosted their price target on Integer from $140.00 to $150.00 and gave the company a "buy" rating in a report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Integer presently has a consensus rating of "Moderate Buy" and a consensus price target of $147.67.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.